StonvexLoading…
StonvexStonvexStonvexCore line items from RJF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $8.44B | $4.18B | $15.91B | $11.72B |
Operating Income | Not available | Not available | Not available | $1.98B |
Net Income | $1.11B | $563.00M | $2.13B | $1.53B |
EPS (Diluted) | $5.51 | $2.79 | $10.30 | $7.35 |
Total Assets | $91.94B | $88.76B | $88.23B | $84.81B |
Total Liabilities | $79.33B | $76.19B | $75.73B | $72.55B |
Cash & Equivalents | $11.22B | $9.89B | $11.39B | $9.20B |
Free Cash Flow OCF − CapEx | $998.00M | $-56.00M | $2.25B | $1.49B |
Shares Outstanding | 194.64M | 197.00M | 198.14M | 199.99M |